查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1661811

莱姆病诊断市场报告：2031 年趋势、预测与竞争分析

Lyme Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球莱姆病诊断市场未来前景光明，在医院和诊所、病理实验室、製药业和临床研究机构市场都存在机会。预计到 2031 年全球莱姆病诊断市场规模将达到 19 亿美元，2025 年至 2031 年的复合年增长率为 3.6%。该市场的主要驱动力是政府重视改善医疗设施、开发莱姆病的新型诊断工具以及主要企业对莱姆病诊断研究和开发的兴趣日益浓厚。

  • Lucintel 预测，在整个预测期内，血清学测试仍将是诊断测试类别中最大的一部分，因为这些测试专注于检测受感染个体体内针对抗原产生的抗体。
  • 根据地区划分，由于医疗成本的上升和新产品的推出，预计北美将在预测期内实现最高增长。

莱姆病诊断市场的策略性成长机会

莱姆病诊断市场的策略性成长机会正在各种关键应用领域涌现。

  • 早期检测技术：能够早期准确检测莱姆病的检测方法的开发可以大大改善患者的治疗效果。
  • 照护现场检测：扩大就地检验选项以改善偏远和服务不足地区的检测服务，是一个成长机会。
  • 数位健康整合：利用数位健康工具和远端医疗来诊断和管理莱姆病可以加强对病患的照护。
  • 扩大全球市场：随着人们对蜱传疾病的认识不断提高，进入新兴市场具有巨大的成长潜力。
  • 经济高效的解决方案：透过开发适合不同医疗保健系统的经济实惠的诊断测试来占领新的细分市场。
  • 加强研究合作：与全球研究机构合作推广诊断方法和技术可以促进创新。

莱姆病诊断市场的策略性成长机会受到早期检测、PoC 测试和全球扩张方面的进步的推动，为市场发展提供了多种途径。

莱姆病诊断市场驱动因素与挑战

莱姆病诊断市场受到影响其成长和发展的各种驱动因素​​和挑战的影响。

推动莱姆病诊断市场发展的因素有：

  • 提高认识：对莱姆病及其症状的认识提高导致了对诊断测试的需求增加。
  • 监管支援：良好的法规环境和更新有助于引入新的诊断技术。
  • 研究经费：研发投入的增加正在刺激先进诊断技术的发展。
  • 卫生基础设施：卫生基础设施和诊断中心的改善扩大了侦测能力。
  • 全球扩张：人们对医疗保健的认识和投资不断增长，将透过拓展新市场提供成长机会。

莱姆病诊断市场面临的挑战是：

  • 高成本：先进诊断测试的成本可能限制其普及，尤其是在资源匮乏的地区。
  • 诊断复杂性：莱姆病的诊断很复杂，包括与其他疾病的区分，可能具有挑战性。
  • 监管障碍：获得新诊断技术的监管要求和批准需要时间。
  • 市场竞争：诊断製造商之间的激烈竞争可能会影响市场占有率和盈利。
  • 缺乏标准化：不同地区的诊断标准和实践有所不同，这可能会影响结果的一致性。
  • 部分地区认知度低：部分地区对莱姆病的认识和了解不足，可能会阻碍市场成长。

莱姆病诊断市场受技术进步和认识不断提高的推动，但面临着高成本和监管障碍等挑战，需要采取策略方法来确保持续成长和可及性。

目录

第一章执行摘要

2. 全球莱姆病诊断市场：市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

  • 宏观经济趋势（2019-2024）与预测（2025-2031）
  • 全球莱姆病诊断市场趋势（2019-2024 年）及预测（2025-2031 年）
  • 全球莱姆病诊断市场（按诊断测试）
    • 血清学检测
    • 核酸扩增技术
    • 尿液抗原检测
    • 淋巴球转化试验
    • 萤光萤光染色
    • PCR 分析
    • 其他的
  • 全球莱姆病诊断市场（按技术）
    • 分子诊断
    • 脑部 MRI
    • 脊椎穿刺
    • 心臟超音波图
    • 心电图
    • 单株抗体
    • 流式细胞技术
    • 凝胶微滴法
    • 其他的
  • 全球莱姆病诊断市场（按最终用途划分）
    • 医院和诊所
    • 病理实验室
    • 製药业
    • 临床研究所
    • 其他的

第 4 章区域市场趋势与预测分析（2019-2031 年）

  • 全球莱姆病诊断市场（按地区）
  • 北美莱姆病诊断市场
  • 欧洲莱姆病诊断市场
  • 亚太地区莱姆病诊断市场
  • 世界其他地区的莱姆病诊断市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球莱姆病诊断市场成长机会（按诊断测试）
    • 全球莱姆病诊断市场成长机会（按技术）
    • 全球莱姆病诊断市场成长机会（按最终用途划分）
    • 全球莱姆病诊断市场各区域成长机会
  • 全球莱姆病诊断市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球莱姆病诊断市场产能扩张
    • 全球莱姆病诊断市场的企业合併
    • 认证和许可

第七章主要企业简介

  • LEDLink Optics
  • Carclo Optics
  • Auer Lighting
  • LEDIL Oy
  • FRAEN
  • GAGGIONE
  • Bicom Optics
  • Darkoo Optics
  • Alere
  • Boulder Diagnostics
简介目录

The future of the global lyme disease diagnostic market looks promising with opportunities in the hospital & clinic, pathology lab, pharmaceutical industry, and clinical research institute markets. The global lyme disease diagnostic market is expected to reach an estimated $1.9 billion by 2031 with a CAGR of 3.6% from 2025 to 2031. The major drivers for this market are government emphasis on enhancing healthcare facilities, the development of novel diagnostic tools for Lyme disease, and the increased interest of key players in Lyme disease diagnosis R&D.

  • Lucintel forecasts that, within the diagnostic test category, serological tests will remain the largest segment over the forecast period because they focus on detecting antibodies produced in the body of an infected individual in response to antigens.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period due to rising healthcare costs and the introduction of new products.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Lyme Disease Diagnostic Market

Emerging trends in the Lyme disease diagnostic market highlight advancements in technology and evolving clinical practices.

  • Advanced Diagnostic Technologies: The development of more sensitive and specific tests, including PCR and next-generation sequencing, is enhancing diagnostic accuracy.
  • Point-of-Care Testing: Innovations in point-of-care testing are improving accessibility and convenience for patients and healthcare providers.
  • Integration with Digital Health: Digital health tools and telemedicine are being integrated into diagnostic processes to improve disease management.
  • Standardization of Diagnostic Criteria: Efforts are underway to standardize diagnostic criteria and guidelines to ensure consistency across regions.
  • Increased Research Funding: Growing investment in research is driving the development of new diagnostic methods and technologies.
  • Public Awareness Campaigns: Enhanced public health campaigns are raising awareness about Lyme disease and its symptoms, leading to earlier diagnosis.

Emerging trends in the Lyme disease diagnostic market reflect advancements in technology, an increased focus on point-of-care testing, and efforts to standardize diagnostic criteria, signaling a more accurate and accessible approach to Lyme disease management.

Recent Developments in the Lyme Disease Diagnostic Market

Recent developments in the Lyme disease diagnostic market demonstrate significant progress and innovation.

  • Introduction of New Tests: The market has seen the launch of improved diagnostic tests, including advanced PCR assays and high-resolution serological tests.
  • Regulatory Updates: Regulatory agencies are updating guidelines to incorporate new diagnostic technologies and improve accuracy.
  • Enhanced Research Initiatives: Increased funding and research are leading to the development of novel diagnostic methods and technologies.
  • Expansion of Diagnostic Centers: The establishment of specialized diagnostic centers in endemic regions is improving testing accessibility.
  • Increased Collaboration: Partnerships between research institutions and industry players are driving innovation in diagnostic technologies.
  • Focus on Rapid Testing: The development of rapid diagnostic tests is making it easier to diagnose Lyme disease promptly and accurately.

Recent developments in the Lyme disease diagnostic market highlight advancements in testing technologies, regulatory updates, and increased research, contributing to more accurate and accessible diagnostics.

Strategic Growth Opportunities for Lyme Disease Diagnostic Market

Strategic growth opportunities in the Lyme disease diagnostic market are emerging across various key applications.

  • Early Detection Technologies: Developing tests that offer early and accurate detection of Lyme disease can significantly improve patient outcomes.
  • Point-of-Care Testing: Expanding point-of-care testing options to increase accessibility in remote and underserved areas presents a growth opportunity.
  • Integration with Digital Health: Leveraging digital health tools and telemedicine for Lyme disease diagnostics and management can enhance patient care.
  • Global Market Expansion: Entering emerging markets with increasing awareness of tick-borne diseases offers significant growth potential.
  • Cost-Effective Solutions: Developing affordable diagnostic tests suitable for diverse healthcare systems can capture new market segments.
  • Enhanced Research Collaboration: Collaborating with global research institutions to advance diagnostic methods and technologies can drive innovation.

Strategic growth opportunities in the Lyme disease diagnostic market are driven by advancements in early detection, point-of-care testing, and global expansion, offering diverse avenues for market development.

Lyme Disease Diagnostic Market Driver and Challenges

The Lyme disease diagnostic market is shaped by various drivers and challenges influencing its growth and development.

The factors responsible for driving the Lyme disease diagnostic market include:

  • Increased Awareness: Growing awareness about Lyme disease and its symptoms is leading to higher demand for diagnostic tests.
  • Regulatory Support: Favorable regulatory environments and updates are facilitating the introduction of new diagnostic technologies.
  • Research Funding: Increased investment in research is driving the development of advanced diagnostic methods.
  • Healthcare Infrastructure: Improvements in healthcare infrastructure and diagnostic centers are expanding testing capabilities.
  • Global Expansion: Expanding into new markets with rising awareness and healthcare investments presents growth opportunities.

Challenges in the Lyme disease diagnostic market include:

  • High Costs: The cost of advanced diagnostic tests can limit accessibility, particularly in low-resource settings.
  • Diagnostic Complexity: The complexity of Lyme disease diagnostics, including differentiation from other diseases, can be challenging.
  • Regulatory Hurdles: Navigating regulatory requirements and approvals for new diagnostic technologies can be time-consuming.
  • Market Competition: Intense competition among diagnostic manufacturers can impact market share and profitability.
  • Lack of Standardization: Variability in diagnostic criteria and practices across regions can affect the consistency of results.
  • Limited Awareness in Some Regions: Inadequate awareness and understanding of Lyme disease in certain areas can hinder market growth.

The Lyme disease diagnostic market is driven by technological advancements and increased awareness but faces challenges such as high costs and regulatory hurdles, requiring strategic approaches to ensure sustained growth and accessibility.

List of Lyme Disease Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies lyme disease diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lyme disease diagnostic companies profiled in this report include-

  • Abbott Laboratories
  • Qiagen
  • Biosystems
  • Bio-Rad Laboratories
  • Immunetics
  • Roche Diagnostics
  • T2 Biosystems
  • Graphene Frontiers
  • Alere
  • Boulder Diagnostics

Lyme Disease Diagnostic by Segment

The study includes a forecast for the global lyme disease diagnostic market by diagnostic test, technology, end use, and region.

Lyme Disease Diagnostic Market by Diagnostic Test [Analysis by Value from 2019 to 2031]:

  • Serological Test
  • Nucleic Acid Amplification Techniques
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Immunofluorescent Staining
  • PCR Analysis
  • Others

Lyme Disease Diagnostic Market by Technology [Analysis by Value from 2019 to 2031]:

  • Molecular Diagnostics
  • Brain MRI
  • Spinal Tap
  • Echocardiogram
  • Electrocardiogram
  • Monoclonal Antibodies
  • Flow Cytometry
  • Gel Microdroplets
  • Others

Lyme Disease Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

  • Hospitals & Clinics
  • Pathology labs
  • Pharmaceutical Industries
  • Clinical Research Institute
  • Others

Lyme Disease Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Lyme Disease Diagnostic Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major Lyme disease diagnostic producers in key regions: the USA, China, India, and Japan.

  • USA: In the U.S., the Lyme disease diagnostic market is evolving with advances in testing technologies and increased awareness. Recent developments include the introduction of more sensitive and specific diagnostic tests, such as improved PCR assays and serological tests that offer better early detection and differentiation from other tick-borne diseases. The CDC has been updating its guidelines to reflect new diagnostic methods and improve diagnostic accuracy. Additionally, there is a growing emphasis on developing point-of-care tests and integrating digital health tools to enhance disease management. Increased funding for research and public health campaigns is also contributing to market growth.
  • China: China's Lyme disease diagnostic market is expanding with improvements in testing technology and increased awareness of tick-borne diseases. Recent developments include the adoption of more advanced diagnostic tests and the establishment of specialized diagnostic centers in endemic regions. China is also investing in research to develop new diagnostic methods and enhance existing ones. Government health initiatives are focusing on improving disease surveillance and diagnostic capabilities. Additionally, there is a growing collaboration between Chinese and international research institutions to advance Lyme disease diagnostics and control measures.
  • India: In India, the Lyme disease diagnostic market is in the early stages of development, with recent advancements focusing on increasing awareness and improving diagnostic capabilities. Efforts are being made to introduce more reliable diagnostic tests and integrate them into public health programs. Research institutions are working on developing cost-effective diagnostic solutions suitable for the Indian healthcare system. Increased collaboration with international organizations and funding for research are helping to improve diagnostic infrastructure and support the development of better testing methods. Public health campaigns are also aiming to raise awareness about Lyme disease and its diagnosis.
  • Japan: Japan's Lyme disease diagnostic market is seeing gradual progress with the introduction of advanced diagnostic technologies and increased research activities. Recent developments include the implementation of more sensitive diagnostic tests, such as enhanced serological and molecular assays. The Japanese government is supporting research initiatives to improve diagnostic accuracy and early detection. There is also an emphasis on educating healthcare professionals and enhancing diagnostic capabilities in endemic areas. Collaborative efforts between Japanese research institutions and international organizations are contributing to the advancement of Lyme disease diagnostics.

Features of the Global Lyme Disease Diagnostic Market

Market Size Estimates: Lyme disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Lyme disease diagnostic market size by diagnostic test, technology, end use, and region in terms of value ($B).

Regional Analysis: Lyme disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic test, technology, end use, and regions for the lyme disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lyme disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the lyme disease diagnostic market by diagnostic test (serological test, nucleic acid amplification techniques, urine antigen tests, lymphocytic transformation test, immunofluorescent staining, PCR Analysis, and others), technology (molecular diagnostics, brain MRI, spinal tap, echocardiogram, electrocardiogram, monoclonal antibodies, flow cytometry, gel microdroplets, and others), end use (hospitals & clinics, pathology labs, pharmaceutical industries, clinical research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Lyme Disease Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Lyme Disease Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Lyme Disease Diagnostic Market by Diagnostic Test
    • 3.3.1: Serological Test
    • 3.3.2: Nucleic Acid Amplification Techniques
    • 3.3.3: Urine Antigen Tests
    • 3.3.4: Lymphocytic Transformation Test
    • 3.3.5: Immunofluorescent Staining
    • 3.3.6: PCR Analysis
    • 3.3.7: Others
  • 3.4: Global Lyme Disease Diagnostic Market by Technology
    • 3.4.1: Molecular Diagnostics
    • 3.4.2: Brain MRI
    • 3.4.3: Spinal Tap
    • 3.4.4: Echocardiogram
    • 3.4.5: Electrocardiogram
    • 3.4.6: Monoclonal Antibodies
    • 3.4.7: Flow Cytometry
    • 3.4.8: Gel Microdroplets
    • 3.4.9: Others
  • 3.5: Global Lyme Disease Diagnostic Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Pathology labs
    • 3.5.3: Pharmaceutical Industries
    • 3.5.4: Clinical Research Institute
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Lyme Disease Diagnostic Market by Region
  • 4.2: North American Lyme Disease Diagnostic Market
    • 4.2.1: North American Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.2.2: North American Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
  • 4.3: European Lyme Disease Diagnostic Market
    • 4.3.1: European Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.3.2: European Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
  • 4.4: APAC Lyme Disease Diagnostic Market
    • 4.4.1: APAC Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.4.2: APAC Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others
  • 4.5: ROW Lyme Disease Diagnostic Market
    • 4.5.1: ROW Market by Diagnostic Test: Serological Test, Nucleic Acid Amplification Techniques, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, PCR Analysis, and Others
    • 4.5.2: ROW Market by End Use: Hospitals & Clinics, Pathology labs, Pharmaceutical Industries, Clinical Research Institute , and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Diagnostic Test
    • 6.1.2: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Technology
    • 6.1.3: Growth Opportunities for the Global Lyme Disease Diagnostic Market by End Use
    • 6.1.4: Growth Opportunities for the Global Lyme Disease Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Lyme Disease Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Lyme Disease Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lyme Disease Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: LEDLink Optics
  • 7.2: Carclo Optics
  • 7.3: Auer Lighting
  • 7.4: LEDIL Oy
  • 7.5: FRAEN
  • 7.6: GAGGIONE
  • 7.7: Bicom Optics
  • 7.8: Darkoo Optics
  • 7.9: Alere
  • 7.10: Boulder Diagnostics